Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,344,641
-
Share change
-
+197,039
-
Total reported value
-
$253,373,000
-
Price per share
-
$11.37
-
Number of holders
-
47
-
Value change
-
+$1,982,516
-
Number of buys
-
24
-
Number of sells
-
10
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q4 2021
As of 31 Dec 2021,
CYTEIR THERAPEUTICS INC - COM (CYTT) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,344,641 shares.
The largest 10 holders included
Novo Holdings A/S, FMR LLC, RA CAPITAL MANAGEMENT, L.P., OUP Management Co., LLC, JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, BAKER BROS. ADVISORS LP, BlackRock Inc., CAAS CAPITAL MANAGEMENT LP, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.